RxResults
Home | Pharmacy Benefit Solutions | RxResults.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
$4.0m | Early VC | ||
| Total Funding | 000k | ||
| USD | 2019 | 2021 | 2023 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
RxResults operates in the healthcare sector, specializing in evidence-based pharmacy risk management. The company serves health plan sponsors and their participants, providing an independent and unbiased evaluation of pharmacy claims data. RxResults leverages proprietary informatics and clinical expertise to identify cost-saving opportunities and mitigate risks associated with rising specialty drug costs and prescription non-adherence. The business model focuses on enhancing existing Pharmacy Benefit Manager (PBM) models rather than replacing them, acting as an advocate for both the plan sponsor and participants. Revenue is generated through consulting fees and performance-based savings. RxResults is uniquely positioned to address the financial impact of pharmacy spend on health plans by implementing well-researched, clinically relevant strategies.
Keywords: pharmacy risk management, health plan savings, PBM enhancement, specialty drugs, prescription adherence, clinical expertise, unbiased evaluation, proprietary informatics, cost mitigation, healthcare sector.